Mahaffey, KW; Jardine, M; Bompoint, S; Cannon, C; Bruce, N; Herspink, LHJ; Charytan, D; ... Perkovic, V; + view all (2019) Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial. Circulation , 140 (9) pp. 739-750. 10.1161/CIRCULATIONAHA.119.042007. Green open access